Table 1.
Baseline patient information
| Indexes | Range | x̅ ± sd | n, (%) |
|---|---|---|---|
| Age (years) | 59-85 | 70.8±7.9 | |
| Sex (male/female) | 5 (50.00%)/5 (50.00%) | ||
| Duration of VP (mo) | 23-192 | 82.76±45.21 | |
| RVP percentage (%) | 40-99 | 83.96±17.87 | |
| Pre-LBBAP EF (%) | 31-70.2 | 47.58±15.27 | |
| Systolic BP (mmHg) | 101-160 | 131.72±19.63 | |
| Diastolic BP (mmHg) | 45-97 | 72.60±14.17 | |
| Blood glucose (mmol/L) | 5.2-7.1 | 6.45±0.64 | |
| Creatinine (μmol/L) | 63-139 | 81.54±24.32 | |
| Beta natriuretic peptide (pg/mL) | 220-13482 | 2863.77±3935.68 | |
| Medical history information | |||
| Hypertension | 7 (70.00%) | ||
| Hypercholesterolemia | 1 (10.00%) | ||
| Type 2 diabetes mellitus | 1 (10.00%) | ||
| Prior myocardial infarction | 0 (0.00%) | ||
| History of atrial fibrillation | 5 (50.00%) | ||
| Percutaneous coronary intervention | 1 (10.00%) | ||
| Coronary artery bypass surgery | 0 (0.00%) | ||
| Previous ICD | 0 (0.00%) | ||
| Valve surgery | 1 (10.00%) | ||
| NYHA heart failure class | |||
| Class II | 6 (60.00%) | ||
| Class III-IV | 4 (40.00%) | ||
| Medications | |||
| Beta blockers | 4 (40.00%) | ||
| Aspirin/antithrombotics | 2 (20.00%) | ||
| Lipid lowering agents | 3 (30.00%) | ||
| Diuretics | 4 (40.00%) | ||
| ACEI/ARB | 7 (70.00%) | ||
| Digoxin | 1 (10.00%) | ||
| Hypoglycemics | 1 (10.00%) | ||
| Antidepressants/antianxiety | 0 (0.00%) | ||
| Vasodilators | 10 (100.00%) |